P7771
乙胺嘧啶
别名:
6-乙基-5-(4-氯苯基)-2,4-嘧啶二胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H13ClN4
化学文摘社编号:
分子量:
248.71
EC Number:
200-364-2
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
219864
MDL number:
InChI key
WKSAUQYGYAYLPV-UHFFFAOYSA-N
InChI
1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)
SMILES string
CCC1=NC(N)=NC(N)=C1C2=CC=C(Cl)C=C2
Gene Information
human ... CYP2C9(1559), DHFRP1(573971)
rat ... Dhfr(24312)
正在寻找类似产品? 访问 产品对比指南
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
新产品
此项目有
Alexis Nzila et al.
Antimicrobial agents and chemotherapy, 54(6), 2603-2610 (2010-03-31)
Drug resistance against dihydrofolate reductase (DHFR) inhibitors-such as pyrimethamine (PM)-has now spread to almost all regions where malaria is endemic, rendering antifolate-based malaria treatments highly ineffective. We have previously shown that the di-amino quinazoline QN254 [5-chloro-N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine] is active against the
Tao Wu et al.
Journal of medicinal chemistry, 54(14), 5116-5130 (2011-06-08)
Starting from a hit series from a GNF compound library collection and based on a cell-based proliferation assay of Plasmodium falciparum, a novel imidazolopiperazine scaffold was optimized. SAR for this series of compounds is discussed, focusing on optimization of cellular
Alyson M Auliff et al.
Antimicrobial agents and chemotherapy, 54(9), 3927-3932 (2010-06-23)
Plasmodium vivax resistance to antifolates is prevalent throughout Australasia and is caused by point mutations within the parasite dihydrofolate reductase (DHFR)-thymidylate synthase. Several unique mutations have been reported in P. vivax DHFR, and their roles in resistance to classic and
Ramesh Gujjar et al.
Journal of medicinal chemistry, 54(11), 3935-3949 (2011-04-27)
Malaria is one of the leading causes of severe infectious disease worldwide; yet, our ability to maintain effective therapy to combat the illness is continually challenged by the emergence of drug resistance. We previously reported identification of a new class
Mari Luntamo et al.
Tropical medicine & international health : TM & IH, 18(4), 386-397 (2013-02-26)
To examine the potential to reduce foetal and neonatal growth faltering through intermittent preventive treatment in pregnancy (IPTp) of malaria and reproductive tract infections with monthly sulphadoxine-pyrimethamine (SP), alone or with two doses of azithromycin. We enrolled 1320 women with
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持